The PE Ratio as of November 2025 (TTM) for Marinus Pharmaceuticals, Inc. (MRNS) is -0.22

According to Marinus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.22. This represents a change of -72.97% compared to the average of -0.82 of the last 4 quarters.

Marinus Pharmaceuticals, Inc. (MRNS) Historical PE Ratio (quarterly & annually)

How has MRNS PE Ratio performed in the past?

The mean historical PE Ratio of Marinus Pharmaceuticals, Inc. over the last ten years is -1.20. The current -0.22 PE Ratio has changed 1.75% with respect to the historical average. Over the past ten years (40 quarters), MRNS's PE Ratio was at its highest in in the September 2022 quarter at 0.22. The PE Ratio was at its lowest in in the December 2017 quarter at -4.35.

Marinus Pharmaceuticals, Inc. (MRNS) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Marinus Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Marinus Pharmaceuticals, Inc. (MRNS) Average PE Ratio

How has MRNS PE Ratio performed in the past?

The current PE Ratio of Marinus Pharmaceuticals, Inc. (MRNS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Marinus Pharmaceuticals, Inc. (MRNS) PE Ratio vs. Peers

How is MRNS’s PE Ratio compared to its peers?

Marinus Pharmaceuticals, Inc.’s PE Ratio is greater than Angion Biomedica Corp. (-0.27), greater than Allakos Inc. (-0.42), greater than Lunai Bioworks Inc. (-0.24), greater than Serina Therapeutics, Inc. (-2.80), greater than Freeline Therapeutics Holdings plc (-0.29), greater than AnPac Bio-Medical Science Co., Ltd. (-0.56), greater than Opus Genetics, Inc. (-2.40), less than LianBio (4.68), greater than IsoPlexis Corporation (-0.26), less than HEXO Corp. (-0.02),

Build a custom stock screener for Marinus Pharmaceuticals, Inc. (MRNS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marinus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Marinus Pharmaceuticals, Inc. (MRNS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Marinus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.